APO Research
Talk to an analyst

APO RESEARCH · REPORT

General Medicines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global General Medicines Market Analysis and Forecast 2026-2032

30 December 2025218 pages

Choose your research edition.

Industry ResearchGeneral Medicines Industry Research Report 2026147 pages · $2,950 USDIndustry Growth & TrendsGlobal General Medicines Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal General Medicines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal General Medicines Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal General Medicines Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global General Medicines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for General Medicines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for General Medicines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for General Medicines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for General Medicines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of General Medicines include Sun Pharmaceutical, Sanofi, Johnson & Johnson, Novartis, Merck, Roche, Eli Lilly, Pfizer and Jiangsu Hengrui Medicine, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for General Medicines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of General Medicines, also provides the sales of main regions and countries. Of the upcoming market potential for General Medicines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the General Medicines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global General Medicines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for General Medicines sales, projected growth trends, production technology, application and end-user industry.

General Medicines Segment by Company

Sun Pharmaceutical

Sanofi

Johnson & Johnson

Novartis

Merck

Roche

Eli Lilly

Pfizer

Jiangsu Hengrui Medicine

Bayer

Amgen

AbbVie

AstraZeneca

Zoetis

Vertex Pharmaceuticals

Takeda Pharmaceutical

Seagen

Regeneron Pharmaceuticals

Novo Nordisk

Moderna

Lonza

Horizon Therapeutics

GlaxoSmithKline

Gilead Sciences

Daiichi Sankyō

CVS Health

Chugai Pharmaceutical

Bristol-Myers Squibb

Biogen

Argenx

General Medicines Segment by Type

Over-the-Counter (OTC)

Prescription (Rx)

General Medicines Segment by Application

Antihypertensives

Antibiotics

Antidiabetic Drugs

Antipyretics

Analgesics

Others

General Medicines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global General Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of General Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of General Medicines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of General Medicines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of General Medicines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, General Medicines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global General Medicines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Over-the-Counter (OTC) Major Manufacturers Table 3. Prescription (Rx) Major Manufacturers Table 4. Global General Medicines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Antihypertensives Major Manufacturers Table 6. Antibiotics Major Manufacturers Table 7. Antidiabetic Drugs Major Manufacturers Table 8. Antipyretics Major Manufacturers Table 9. Analgesics Major Manufacturers Table 10. Others Major Manufacturers Table 11. General Medicines Industry Trends Table 12. General Medicines Industry Drivers Table 13. General Medicines Industry Opportunities and Challenges Table 14. General Medicines Industry Restraints Table 15. Global General Medicines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global General Medicines Revenue by Region (2021-2026) & (US$ Million) Table 17. Global General Medicines Revenue by Region (2027-2032) & (US$ Million) Table 18. Global General Medicines Revenue Market Share by Region (2021-2026) Table 19. Global General Medicines Revenue Market Share by Region (2027-2032) Table 20. Global General Medicines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global General Medicines Sales by Region (2021-2026) & (K Units) Table 22. Global General Medicines Sales by Region (2027-2032) & (K Units) Table 23. Global General Medicines Sales Market Share by Region (2021-2026) Table 24. Global General Medicines Sales Market Share by Region (2027-2032) Table 25. Global General Medicines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global General Medicines Revenue Market Share by Manufacturers (2021-2026) Table 27. Global General Medicines Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global General Medicines Sales Market Share by Manufacturers (2021-2026) Table 29. Global General Medicines Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global General Medicines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global General Medicines Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global General Medicines Manufacturers, Product Type & Application Table 33. Global General Medicines Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global General Medicines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global General Medicines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global General Medicines Revenue by Type (2021-2026) & (US$ Million) Table 38. Global General Medicines Revenue by Type (2027-2032) & (US$ Million) Table 39. Global General Medicines Revenue Market Share by Type (2021-2026) Table 40. Global General Medicines Revenue Market Share by Type (2027-2032) Table 41. Global General Medicines Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global General Medicines Sales by Type (2021-2026) & (K Units) Table 43. Global General Medicines Sales by Type (2027-2032) & (K Units) Table 44. Global General Medicines Sales Market Share by Type (2021-2026) Table 45. Global General Medicines Sales Market Share by Type (2027-2032) Table 46. Global General Medicines Price by Type (2021-2026) & (US$/Unit) Table 47. Global General Medicines Price by Type (2027-2032) & (US$/Unit) Table 48. Global General Medicines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global General Medicines Revenue by Application (2021-2026) & (US$ Million) Table 50. Global General Medicines Revenue by Application (2027-2032) & (US$ Million) Table 51. Global General Medicines Revenue Market Share by Application (2021-2026) Table 52. Global General Medicines Revenue Market Share by Application (2027-2032) Table 53. Global General Medicines Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global General Medicines Sales by Application (2021-2026) & (K Units) Table 55. Global General Medicines Sales by Application (2027-2032) & (K Units) Table 56. Global General Medicines Sales Market Share by Application (2021-2026) Table 57. Global General Medicines Sales Market Share by Application (2027-2032) Table 58. Global General Medicines Price by Application (2021-2026) & (US$/Unit) Table 59. Global General Medicines Price by Application (2027-2032) & (US$/Unit) Table 60. Sun Pharmaceutical Company Information Table 61. Sun Pharmaceutical Business Overview Table 62. Sun Pharmaceutical General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Sun Pharmaceutical General Medicines Product Portfolio Table 64. Sun Pharmaceutical Recent Development Table 65. Sanofi Company Information Table 66. Sanofi Business Overview Table 67. Sanofi General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Sanofi General Medicines Product Portfolio Table 69. Sanofi Recent Development Table 70. Johnson & Johnson Company Information Table 71. Johnson & Johnson Business Overview Table 72. Johnson & Johnson General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Johnson & Johnson General Medicines Product Portfolio Table 74. Johnson & Johnson Recent Development Table 75. Novartis Company Information Table 76. Novartis Business Overview Table 77. Novartis General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Novartis General Medicines Product Portfolio Table 79. Novartis Recent Development Table 80. Merck Company Information Table 81. Merck Business Overview Table 82. Merck General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Merck General Medicines Product Portfolio Table 84. Merck Recent Development Table 85. Roche Company Information Table 86. Roche Business Overview Table 87. Roche General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Roche General Medicines Product Portfolio Table 89. Roche Recent Development Table 90. Eli Lilly Company Information Table 91. Eli Lilly Business Overview Table 92. Eli Lilly General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Eli Lilly General Medicines Product Portfolio Table 94. Eli Lilly Recent Development Table 95. Pfizer Company Information Table 96. Pfizer Business Overview Table 97. Pfizer General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Pfizer General Medicines Product Portfolio Table 99. Pfizer Recent Development Table 100. Jiangsu Hengrui Medicine Company Information Table 101. Jiangsu Hengrui Medicine Business Overview Table 102. Jiangsu Hengrui Medicine General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Jiangsu Hengrui Medicine General Medicines Product Portfolio Table 104. Jiangsu Hengrui Medicine Recent Development Table 105. Bayer Company Information Table 106. Bayer Business Overview Table 107. Bayer General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Bayer General Medicines Product Portfolio Table 109. Bayer Recent Development Table 110. Amgen Company Information Table 111. Amgen Business Overview Table 112. Amgen General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Amgen General Medicines Product Portfolio Table 114. Amgen Recent Development Table 115. AbbVie Company Information Table 116. AbbVie Business Overview Table 117. AbbVie General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. AbbVie General Medicines Product Portfolio Table 119. AbbVie Recent Development Table 120. AstraZeneca Company Information Table 121. AstraZeneca Business Overview Table 122. AstraZeneca General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. AstraZeneca General Medicines Product Portfolio Table 124. AstraZeneca Recent Development Table 125. Zoetis Company Information Table 126. Zoetis Business Overview Table 127. Zoetis General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Zoetis General Medicines Product Portfolio Table 129. Zoetis Recent Development Table 130. Vertex Pharmaceuticals Company Information Table 131. Vertex Pharmaceuticals Business Overview Table 132. Vertex Pharmaceuticals General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Vertex Pharmaceuticals General Medicines Product Portfolio Table 134. Vertex Pharmaceuticals Recent Development Table 135. Takeda Pharmaceutical Company Information Table 136. Takeda Pharmaceutical Business Overview Table 137. Takeda Pharmaceutical General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Takeda Pharmaceutical General Medicines Product Portfolio Table 139. Takeda Pharmaceutical Recent Development Table 140. Seagen Company Information Table 141. Seagen Business Overview Table 142. Seagen General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. Seagen General Medicines Product Portfolio Table 144. Seagen Recent Development Table 145. Regeneron Pharmaceuticals Company Information Table 146. Regeneron Pharmaceuticals Business Overview Table 147. Regeneron Pharmaceuticals General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. Regeneron Pharmaceuticals General Medicines Product Portfolio Table 149. Regeneron Pharmaceuticals Recent Development Table 150. Novo Nordisk Company Information Table 151. Novo Nordisk Business Overview Table 152. Novo Nordisk General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 153. Novo Nordisk General Medicines Product Portfolio Table 154. Novo Nordisk Recent Development Table 155. Moderna Company Information Table 156. Moderna Business Overview Table 157. Moderna General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 158. Moderna General Medicines Product Portfolio Table 159. Moderna Recent Development Table 160. Lonza Company Information Table 161. Lonza Business Overview Table 162. Lonza General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 163. Lonza General Medicines Product Portfolio Table 164. Lonza Recent Development Table 165. Horizon Therapeutics Company Information Table 166. Horizon Therapeutics Business Overview Table 167. Horizon Therapeutics General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 168. Horizon Therapeutics General Medicines Product Portfolio Table 169. Horizon Therapeutics Recent Development Table 170. GlaxoSmithKline Company Information Table 171. GlaxoSmithKline Business Overview Table 172. GlaxoSmithKline General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 173. GlaxoSmithKline General Medicines Product Portfolio Table 174. GlaxoSmithKline Recent Development Table 175. Gilead Sciences Company Information Table 176. Gilead Sciences Business Overview Table 177. Gilead Sciences General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 178. Gilead Sciences General Medicines Product Portfolio Table 179. Gilead Sciences Recent Development Table 180. Daiichi Sankyō Company Information Table 181. Daiichi Sankyō Business Overview Table 182. Daiichi Sankyō General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 183. Daiichi Sankyō General Medicines Product Portfolio Table 184. Daiichi Sankyō Recent Development Table 185. CVS Health Company Information Table 186. CVS Health Business Overview Table 187. CVS Health General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 188. CVS Health General Medicines Product Portfolio Table 189. CVS Health Recent Development Table 190. Chugai Pharmaceutical Company Information Table 191. Chugai Pharmaceutical Business Overview Table 192. Chugai Pharmaceutical General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 193. Chugai Pharmaceutical General Medicines Product Portfolio Table 194. Chugai Pharmaceutical Recent Development Table 195. Bristol-Myers Squibb Company Information Table 196. Bristol-Myers Squibb Business Overview Table 197. Bristol-Myers Squibb General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 198. Bristol-Myers Squibb General Medicines Product Portfolio Table 199. Bristol-Myers Squibb Recent Development Table 200. Biogen Company Information Table 201. Biogen Business Overview Table 202. Biogen General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 203. Biogen General Medicines Product Portfolio Table 204. Biogen Recent Development Table 205. Argenx Company Information Table 206. Argenx Business Overview Table 207. Argenx General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 208. Argenx General Medicines Product Portfolio Table 209. Argenx Recent Development Table 210. North America General Medicines Revenue by Type (2021-2026) & (US$ Million) Table 211. North America General Medicines Revenue by Type (2027-2032) & (US$ Million) Table 212. North America General Medicines Sales by Type (2021-2026) & (K Units) Table 213. North America General Medicines Sales by Type (2027-2032) & (K Units) Table 214. North America General Medicines Sales Price by Type (2021-2026) & (US$/Unit) Table 215. North America General Medicines Sales Price by Type (2027-2032) & (US$/Unit) Table 216. North America General Medicines Revenue by Application (2021-2026) & (US$ Million) Table 217. North America General Medicines Revenue by Application (2027-2032) & (US$ Million) Table 218. North America General Medicines Sales by Application (2021-2026) & (K Units) Table 219. North America General Medicines Sales by Application (2027-2032) & (K Units) Table 220. North America General Medicines Sales Price by Application (2021-2026) & (US$/Unit) Table 221. North America General Medicines Sales Price by Application (2027-2032) & (US$/Unit) Table 222. North America General Medicines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 223. North America General Medicines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 224. North America General Medicines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 225. North America General Medicines Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 226. North America General Medicines Sales by Country (2021-2026) & (K Units) Table 227. North America General Medicines Sales by Country (2027-2032) & (K Units) Table 228. North America General Medicines Sales Price by Country (2021-2026) & (US$/Unit) Table 229. North America General Medicines Sales Price by Country (2027-2032) & (US$/Unit) Table 230. United States General Medicines Revenue (2021-2032) & (US$ Million) Table 231. Canada General Medicines Revenue (2021-2032) & (US$ Million) Table 232. Europe General Medicines Revenue by Type (2021-2026) & (US$ Million) Table 233. Europe General Medicines Revenue by Type (2027-2032) & (US$ Million) Table 234. Europe General Medicines Sales by Type (2021-2026) & (K Units) Table 235. Europe General Medicines Sales by Type (2027-2032) & (K Units) Table 236. Europe General Medicines Sales Price by Type (2021-2026) & (US$/Unit) Table 237. Europe General Medicines Sales Price by Type (2027-2032) & (US$/Unit) Table 238. Europe General Medicines Revenue by Application (2021-2026) & (US$ Million) Table 239. Europe General Medicines Revenue by Application (2027-2032) & (US$ Million) Table 240. Europe General Medicines Sales by Application (2021-2026) & (K Units) Table 241. Europe General Medicines Sales by Application (2027-2032) & (K Units) Table 242. Europe General Medicines Sales Price by Application (2021-2026) & (US$/Unit) Table 243. Europe General Medicines Sales Price by Application (2027-2032) & (US$/Unit) Table 244. Europe General Medicines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 245. Europe General Medicines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 246. Europe General Medicines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 247. Europe General Medicines Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 248. Europe General Medicines Sales by Country (2021-2026) & (K Units) Table 249. Europe General Medicines Sales by Country (2027-2032) & (K Units) Table 250. Europe General Medicines Sales Price by Country (2021-2026) & (US$/Unit) Table 251. Europe General Medicines Sales Price by Country (2027-2032) & (US$/Unit) Table 252. Germany General Medicines Revenue (2021-2032) & (US$ Million) Table 253. France General Medicines Revenue (2021-2032) & (US$ Million) Table 254. U.K. General Medicines Revenue (2021-2032) & (US$ Million) Table 255. Italy General Medicines Revenue (2021-2032) & (US$ Million) Table 256. Netherlands General Medicines Revenue (2021-2032) & (US$ Million) Table 257. China General Medicines Revenue by Type (2021-2026) & (US$ Million) Table 258. China General Medicines Revenue by Type (2027-2032) & (US$ Million) Table 259. China General Medicines Sales by Type (2021-2026) & (K Units) Table 260. China General Medicines Sales by Type (2027-2032) & (K Units) Table 261. China General Medicines Sales Price by Type (2021-2026) & (US$/Unit) Table 262. China General Medicines Sales Price by Type (2027-2032) & (US$/Unit) Table 263. China General Medicines Revenue by Application (2021-2026) & (US$ Million) Table 264. China General Medicines Revenue by Application (2027-2032) & (US$ Million) Table 265. China General Medicines Sales by Application (2021-2026) & (K Units) Table 266. China General Medicines Sales by Application (2027-2032) & (K Units) Table 267. China General Medicines Sales Price by Application (2021-2026) & (US$/Unit) Table 268. China General Medicines Sales Price by Application (2027-2032) & (US$/Unit) Table 269. Asia General Medicines Revenue by Type (2021-2026) & (US$ Million) Table 270. Asia General Medicines Revenue by Type (2027-2032) & (US$ Million) Table 271. Asia General Medicines Sales by Type (2021-2026) & (K Units) Table 272. Asia General Medicines Sales by Type (2027-2032) & (K Units) Table 273. Asia General Medicines Sales Price by Type (2021-2026) & (US$/Unit) Table 274. Asia General Medicines Sales Price by Type (2027-2032) & (US$/Unit) Table 275. Asia General Medicines Revenue by Application (2021-2026) & (US$ Million) Table 276. Asia General Medicines Revenue by Application (2027-2032) & (US$ Million) Table 277. Asia General Medicines Sales by Application (2021-2026) & (K Units) Table 278. Asia General Medicines Sales by Application (2027-2032) & (K Units) Table 279. Asia General Medicines Sales Price by Application (2021-2026) & (US$/Unit) Table 280. Asia General Medicines Sales Price by Application (2027-2032) & (US$/Unit) Table 281. Asia General Medicines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 282. Asia General Medicines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 283. Asia General Medicines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 284. Asia General Medicines Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 285. Asia General Medicines Sales by Country (2021-2026) & (K Units) Table 286. Asia General Medicines Sales by Country (2027-2032) & (K Units) Table 287. Asia General Medicines Sales Price by Country (2021-2026) & (US$/Unit) Table 288. Asia General Medicines Sales Price by Country (2027-2032) & (US$/Unit) Table 289. Japan General Medicines Revenue (2021-2032) & (US$ Million) Table 290. South Korea General Medicines Revenue (2021-2032) & (US$ Million) Table 291. India General Medicines Revenue (2021-2032) & (US$ Million) Table 292. Australia General Medicines Revenue (2021-2032) & (US$ Million) Table 293. China Taiwan General Medicines Revenue (2021-2032) & (US$ Million) Table 294. Southeast Asia General Medicines Revenue (2021-2032) & (US$ Million) Table 295. SAMEA General Medicines Revenue by Type (2021-2026) & (US$ Million) Table 296. SAMEA General Medicines Revenue by Type (2027-2032) & (US$ Million) Table 297. SAMEA General Medicines Sales by Type (2021-2026) & (K Units) Table 298. SAMEA General Medicines Sales by Type (2027-2032) & (K Units) Table 299. SAMEA General Medicines Sales Price by Type (2021-2026) & (US$/Unit) Table 300. SAMEA General Medicines Sales Price by Type (2027-2032) & (US$/Unit) Table 301. SAMEA General Medicines Revenue by Application (2021-2026) & (US$ Million) Table 302. SAMEA General Medicines Revenue by Application (2027-2032) & (US$ Million) Table 303. SAMEA General Medicines Sales by Application (2021-2026) & (K Units) Table 304. SAMEA General Medicines Sales by Application (2027-2032) & (K Units) Table 305. SAMEA General Medicines Sales Price by Application (2021-2026) & (US$/Unit) Table 306. SAMEA General Medicines Sales Price by Application (2027-2032) & (US$/Unit) Table 307. SAMEA General Medicines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 308. SAMEA General Medicines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 309. SAMEA General Medicines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 310. SAMEA General Medicines Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 311. SAMEA General Medicines Sales by Country (2021-2026) & (K Units) Table 312. SAMEA General Medicines Sales by Country (2027-2032) & (K Units) Table 313. SAMEA General Medicines Sales Price by Country (2021-2026) & (US$/Unit) Table 314. SAMEA General Medicines Sales Price by Country (2027-2032) & (US$/Unit) Table 315. Brazil General Medicines Revenue (2021-2032) & (US$ Million) Table 316. Argentina General Medicines Revenue (2021-2032) & (US$ Million) Table 317. Chile General Medicines Revenue (2021-2032) & (US$ Million) Table 318. Colombia General Medicines Revenue (2021-2032) & (US$ Million) Table 319. Peru General Medicines Revenue (2021-2032) & (US$ Million) Table 320. Saudi Arabia General Medicines Revenue (2021-2032) & (US$ Million) Table 321. Israel General Medicines Revenue (2021-2032) & (US$ Million) Table 322. UAE General Medicines Revenue (2021-2032) & (US$ Million) Table 323. Turkey General Medicines Revenue (2021-2032) & (US$ Million) Table 324. Iran General Medicines Revenue (2021-2032) & (US$ Million) Table 325. Egypt General Medicines Revenue (2021-2032) & (US$ Million) Table 326. Key Raw Materials Table 327. Raw Materials Key Suppliers Table 328. General Medicines Distributors List Table 329. General Medicines Customers List Table 330. Research Programs/Design for This Report Table 331. Authors List of This Report Table 332. Secondary Sources Table 333. Primary Sources List of Figures Figure 1. General Medicines Image Figure 2. Global General Medicines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global General Medicines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Over-the-Counter (OTC) Image Figure 5. Prescription (Rx) Image Figure 6. Global General Medicines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global General Medicines Market Size Share 2021 VS 2025 VS 2032 Figure 8. Antihypertensives Image Figure 9. Antibiotics Image Figure 10. Antidiabetic Drugs Image Figure 11. Antipyretics Image Figure 12. Analgesics Image Figure 13. Others Image Figure 14. Global General Medicines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global General Medicines Revenue (2021-2032) & (US$ Million) Figure 16. Global General Medicines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global General Medicines Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global General Medicines Revenue Market Share by Region (2021-2032) Figure 19. Global General Medicines Sales (2021-2032) & (K Units) Figure 20. Global General Medicines Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global General Medicines Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico General Medicines Sales YoY (2021-2032) & (K Units) Figure 23. Europe General Medicines Sales YoY (2021-2032) & (K Units) Figure 24. China General Medicines Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) General Medicines Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa General Medicines Sales YoY (2021-2032) & (K Units) Figure 27. Global General Medicines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global General Medicines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global General Medicines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global General Medicines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global General Medicines Revenue Market Share by Type (2021-2032) Figure 33. Global General Medicines Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global General Medicines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global General Medicines Sales Market Share by Type (2021-2032) Figure 36. Global General Medicines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global General Medicines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global General Medicines Revenue Market Share by Application (2021-2032) Figure 39. Global General Medicines Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global General Medicines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global General Medicines Sales Market Share by Application (2021-2032) Figure 42. North America General Medicines Revenue Share by Type (2021-2032) Figure 43. North America General Medicines Sales Share by Type (2021-2032) Figure 44. North America General Medicines Revenue Share by Application (2021-2032) Figure 45. North America General Medicines Sales Share by Application (2021-2032) Figure 46. North America General Medicines Revenue Share by Country (2021-2032) Figure 47. North America General Medicines Sales Share by Country (2021-2032) Figure 48. Europe General Medicines Revenue Share by Type (2021-2032) Figure 49. Europe General Medicines Sales Share by Type (2021-2032) Figure 50. Europe General Medicines Revenue Share by Application (2021-2032) Figure 51. Europe General Medicines Sales Share by Application (2021-2032) Figure 52. Europe General Medicines Revenue Share by Country (2021-2032) Figure 53. Europe General Medicines Sales Share by Country (2021-2032) Figure 54. China General Medicines Revenue Share by Type (2021-2032) Figure 55. China General Medicines Sales Share by Type (2021-2032) Figure 56. China General Medicines Revenue Share by Application (2021-2032) Figure 57. China General Medicines Sales Share by Application (2021-2032) Figure 58. Asia General Medicines Revenue Share by Type (2021-2032) Figure 59. Asia General Medicines Sales Share by Type (2021-2032) Figure 60. Asia General Medicines Revenue Share by Application (2021-2032) Figure 61. Asia General Medicines Sales Share by Application (2021-2032) Figure 62. Asia General Medicines Revenue Share by Country (2021-2032) Figure 63. Asia General Medicines Sales Share by Country (2021-2032) Figure 64. SAMEA General Medicines Revenue Share by Type (2021-2032) Figure 65. SAMEA General Medicines Sales Share by Type (2021-2032) Figure 66. SAMEA General Medicines Revenue Share by Application (2021-2032) Figure 67. SAMEA General Medicines Sales Share by Application (2021-2032) Figure 68. SAMEA General Medicines Revenue Share by Country (2021-2032) Figure 69. SAMEA General Medicines Sales Share by Country (2021-2032) Figure 70. General Medicines Value Chain Figure 71. Manufacturing Cost Structure Figure 72. General Medicines Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Over-the-Counter (OTC)
  • Prescription (Rx)
Applications
  • Antihypertensives
  • Antibiotics
  • Antidiabetic Drugs
  • Antipyretics
  • Analgesics
  • Others
Companies covered
  • Sun Pharmaceutical
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck
  • Roche
  • Eli Lilly
  • Pfizer
  • Jiangsu Hengrui Medicine
  • Bayer
  • Amgen
  • AbbVie
  • AstraZeneca
  • Zoetis
  • Vertex Pharmaceuticals
  • Takeda Pharmaceutical
  • Seagen
  • Regeneron Pharmaceuticals
  • Novo Nordisk
  • Moderna
  • Lonza
  • Horizon Therapeutics
  • GlaxoSmithKline
  • Gilead Sciences
  • Daiichi Sankyō
  • CVS Health
  • Chugai Pharmaceutical
  • Bristol-Myers Squibb
  • Biogen
  • Argenx

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 General Medicines Market by Type
  3. 1.2.1 Global General Medicines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Over-the-Counter (OTC)
  5. 1.2.3 Prescription (Rx)
  6. 1.3 General Medicines Market by Application
  7. 1.3.1 Global General Medicines Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Antihypertensives
  9. 1.3.3 Antibiotics
  10. 1.3.4 Antidiabetic Drugs
  11. 1.3.5 Antipyretics
  12. 1.3.6 Analgesics
  13. 1.3.7 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 General Medicines Market Dynamics
  1. 2.1 General Medicines Industry Trends
  2. 2.2 General Medicines Industry Drivers
  3. 2.3 General Medicines Industry Opportunities and Challenges
  4. 2.4 General Medicines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global General Medicines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global General Medicines Revenue by Region
  3. 3.2.1 Global General Medicines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global General Medicines Revenue by Region (2021-2026)
  5. 3.2.3 Global General Medicines Revenue by Region (2027-2032)
  6. 3.2.4 Global General Medicines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global General Medicines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global General Medicines Sales by Region
  9. 3.4.1 Global General Medicines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global General Medicines Sales by Region (2021-2026)
  11. 3.4.3 Global General Medicines Sales by Region (2027-2032)
  12. 3.4.4 Global General Medicines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global General Medicines Revenue by Manufacturers
  2. 4.1.1 Global General Medicines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global General Medicines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global General Medicines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global General Medicines Sales by Manufacturers
  6. 4.2.1 Global General Medicines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global General Medicines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global General Medicines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global General Medicines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global General Medicines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global General Medicines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global General Medicines Manufacturers, Product Type & Application
  13. 4.7 Global General Medicines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global General Medicines Market CR5 and HHI
  16. 4.8.2 2025 General Medicines Tier 1, Tier 2, and Tier 3
5 General Medicines Market by Type
  1. 5.1 Global General Medicines Revenue by Type
  2. 5.1.1 Global General Medicines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global General Medicines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global General Medicines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global General Medicines Sales by Type
  6. 5.2.1 Global General Medicines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global General Medicines Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global General Medicines Sales Market Share by Type (2021-2032)
  9. 5.3 Global General Medicines Price by Type
6 General Medicines Market by Application
  1. 6.1 Global General Medicines Revenue by Application
  2. 6.1.1 Global General Medicines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global General Medicines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global General Medicines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global General Medicines Sales by Application
  6. 6.2.1 Global General Medicines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global General Medicines Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global General Medicines Sales Market Share by Application (2021-2032)
  9. 6.3 Global General Medicines Price by Application
7 Company Profiles
  1. 7.1 Sun Pharmaceutical
  2. 7.1.1 Sun Pharmaceutical Company Information
  3. 7.1.2 Sun Pharmaceutical Business Overview
  4. 7.1.3 Sun Pharmaceutical General Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sun Pharmaceutical General Medicines Product Portfolio
  6. 7.1.5 Sun Pharmaceutical Recent Developments
  7. 7.2 Sanofi
  8. 7.2.1 Sanofi Company Information
  9. 7.2.2 Sanofi Business Overview
  10. 7.2.3 Sanofi General Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi General Medicines Product Portfolio
  12. 7.2.5 Sanofi Recent Developments
  13. 7.3 Johnson & Johnson
  14. 7.3.1 Johnson & Johnson Company Information
  15. 7.3.2 Johnson & Johnson Business Overview
  16. 7.3.3 Johnson & Johnson General Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Johnson & Johnson General Medicines Product Portfolio
  18. 7.3.5 Johnson & Johnson Recent Developments
  19. 7.4 Novartis
  20. 7.4.1 Novartis Company Information
  21. 7.4.2 Novartis Business Overview
  22. 7.4.3 Novartis General Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Novartis General Medicines Product Portfolio
  24. 7.4.5 Novartis Recent Developments
  25. 7.5 Merck
  26. 7.5.1 Merck Company Information
  27. 7.5.2 Merck Business Overview
  28. 7.5.3 Merck General Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Merck General Medicines Product Portfolio
  30. 7.5.5 Merck Recent Developments
  31. 7.6 Roche
  32. 7.6.1 Roche Company Information
  33. 7.6.2 Roche Business Overview
  34. 7.6.3 Roche General Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Roche General Medicines Product Portfolio
  36. 7.6.5 Roche Recent Developments
  37. 7.7 Eli Lilly
  38. 7.7.1 Eli Lilly Company Information
  39. 7.7.2 Eli Lilly Business Overview
  40. 7.7.3 Eli Lilly General Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Eli Lilly General Medicines Product Portfolio
  42. 7.7.5 Eli Lilly Recent Developments
  43. 7.8 Pfizer
  44. 7.8.1 Pfizer Company Information
  45. 7.8.2 Pfizer Business Overview
  46. 7.8.3 Pfizer General Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Pfizer General Medicines Product Portfolio
  48. 7.8.5 Pfizer Recent Developments
  49. 7.9 Jiangsu Hengrui Medicine
  50. 7.9.1 Jiangsu Hengrui Medicine Company Information
  51. 7.9.2 Jiangsu Hengrui Medicine Business Overview
  52. 7.9.3 Jiangsu Hengrui Medicine General Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Jiangsu Hengrui Medicine General Medicines Product Portfolio
  54. 7.9.5 Jiangsu Hengrui Medicine Recent Developments
  55. 7.10 Bayer
  56. 7.10.1 Bayer Company Information
  57. 7.10.2 Bayer Business Overview
  58. 7.10.3 Bayer General Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Bayer General Medicines Product Portfolio
  60. 7.10.5 Bayer Recent Developments
  61. 7.11 Amgen
  62. 7.11.1 Amgen Company Information
  63. 7.11.2 Amgen Business Overview
  64. 7.11.3 Amgen General Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Amgen General Medicines Product Portfolio
  66. 7.11.5 Amgen Recent Developments
  67. 7.12 AbbVie
  68. 7.12.1 AbbVie Company Information
  69. 7.12.2 AbbVie Business Overview
  70. 7.12.3 AbbVie General Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 AbbVie General Medicines Product Portfolio
  72. 7.12.5 AbbVie Recent Developments
  73. 7.13 AstraZeneca
  74. 7.13.1 AstraZeneca Company Information
  75. 7.13.2 AstraZeneca Business Overview
  76. 7.13.3 AstraZeneca General Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 AstraZeneca General Medicines Product Portfolio
  78. 7.13.5 AstraZeneca Recent Developments
  79. 7.14 Zoetis
  80. 7.14.1 Zoetis Company Information
  81. 7.14.2 Zoetis Business Overview
  82. 7.14.3 Zoetis General Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Zoetis General Medicines Product Portfolio
  84. 7.14.5 Zoetis Recent Developments
  85. 7.15 Vertex Pharmaceuticals
  86. 7.15.1 Vertex Pharmaceuticals Company Information
  87. 7.15.2 Vertex Pharmaceuticals Business Overview
  88. 7.15.3 Vertex Pharmaceuticals General Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Vertex Pharmaceuticals General Medicines Product Portfolio
  90. 7.15.5 Vertex Pharmaceuticals Recent Developments
  91. 7.16 Takeda Pharmaceutical
  92. 7.16.1 Takeda Pharmaceutical Company Information
  93. 7.16.2 Takeda Pharmaceutical Business Overview
  94. 7.16.3 Takeda Pharmaceutical General Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Takeda Pharmaceutical General Medicines Product Portfolio
  96. 7.16.5 Takeda Pharmaceutical Recent Developments
  97. 7.17 Seagen
  98. 7.17.1 Seagen Company Information
  99. 7.17.2 Seagen Business Overview
  100. 7.17.3 Seagen General Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Seagen General Medicines Product Portfolio
  102. 7.17.5 Seagen Recent Developments
  103. 7.18 Regeneron Pharmaceuticals
  104. 7.18.1 Regeneron Pharmaceuticals Company Information
  105. 7.18.2 Regeneron Pharmaceuticals Business Overview
  106. 7.18.3 Regeneron Pharmaceuticals General Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Regeneron Pharmaceuticals General Medicines Product Portfolio
  108. 7.18.5 Regeneron Pharmaceuticals Recent Developments
  109. 7.19 Novo Nordisk
  110. 7.19.1 Novo Nordisk Company Information
  111. 7.19.2 Novo Nordisk Business Overview
  112. 7.19.3 Novo Nordisk General Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Novo Nordisk General Medicines Product Portfolio
  114. 7.19.5 Novo Nordisk Recent Developments
  115. 7.20 Moderna
  116. 7.20.1 Moderna Company Information
  117. 7.20.2 Moderna Business Overview
  118. 7.20.3 Moderna General Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Moderna General Medicines Product Portfolio
  120. 7.20.5 Moderna Recent Developments
  121. 7.21 Lonza
  122. 7.21.1 Lonza Company Information
  123. 7.21.2 Lonza Business Overview
  124. 7.21.3 Lonza General Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Lonza General Medicines Product Portfolio
  126. 7.21.5 Lonza Recent Developments
  127. 7.22 Horizon Therapeutics
  128. 7.22.1 Horizon Therapeutics Company Information
  129. 7.22.2 Horizon Therapeutics Business Overview
  130. 7.22.3 Horizon Therapeutics General Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Horizon Therapeutics General Medicines Product Portfolio
  132. 7.22.5 Horizon Therapeutics Recent Developments
  133. 7.23 GlaxoSmithKline
  134. 7.23.1 GlaxoSmithKline Company Information
  135. 7.23.2 GlaxoSmithKline Business Overview
  136. 7.23.3 GlaxoSmithKline General Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 GlaxoSmithKline General Medicines Product Portfolio
  138. 7.23.5 GlaxoSmithKline Recent Developments
  139. 7.24 Gilead Sciences
  140. 7.24.1 Gilead Sciences Company Information
  141. 7.24.2 Gilead Sciences Business Overview
  142. 7.24.3 Gilead Sciences General Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  143. 7.24.4 Gilead Sciences General Medicines Product Portfolio
  144. 7.24.5 Gilead Sciences Recent Developments
  145. 7.25 Daiichi Sankyō
  146. 7.25.1 Daiichi Sankyō Company Information
  147. 7.25.2 Daiichi Sankyō Business Overview
  148. 7.25.3 Daiichi Sankyō General Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  149. 7.25.4 Daiichi Sankyō General Medicines Product Portfolio
  150. 7.25.5 Daiichi Sankyō Recent Developments
  151. 7.26 CVS Health
  152. 7.26.1 CVS Health Company Information
  153. 7.26.2 CVS Health Business Overview
  154. 7.26.3 CVS Health General Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  155. 7.26.4 CVS Health General Medicines Product Portfolio
  156. 7.26.5 CVS Health Recent Developments
  157. 7.27 Chugai Pharmaceutical
  158. 7.27.1 Chugai Pharmaceutical Company Information
  159. 7.27.2 Chugai Pharmaceutical Business Overview
  160. 7.27.3 Chugai Pharmaceutical General Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  161. 7.27.4 Chugai Pharmaceutical General Medicines Product Portfolio
  162. 7.27.5 Chugai Pharmaceutical Recent Developments
  163. 7.28 Bristol-Myers Squibb
  164. 7.28.1 Bristol-Myers Squibb Company Information
  165. 7.28.2 Bristol-Myers Squibb Business Overview
  166. 7.28.3 Bristol-Myers Squibb General Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  167. 7.28.4 Bristol-Myers Squibb General Medicines Product Portfolio
  168. 7.28.5 Bristol-Myers Squibb Recent Developments
  169. 7.29 Biogen
  170. 7.29.1 Biogen Company Information
  171. 7.29.2 Biogen Business Overview
  172. 7.29.3 Biogen General Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  173. 7.29.4 Biogen General Medicines Product Portfolio
  174. 7.29.5 Biogen Recent Developments
  175. 7.30 Argenx
  176. 7.30.1 Argenx Company Information
  177. 7.30.2 Argenx Business Overview
  178. 7.30.3 Argenx General Medicines Sales, Revenue, Price and Gross Margin (2021-2026)
  179. 7.30.4 Argenx General Medicines Product Portfolio
  180. 7.30.5 Argenx Recent Developments
8 North America
  1. 8.1 North America General Medicines Market Size by Type
  2. 8.1.1 North America General Medicines Revenue by Type (2021-2032)
  3. 8.1.2 North America General Medicines Sales by Type (2021-2032)
  4. 8.1.3 North America General Medicines Price by Type (2021-2032)
  5. 8.2 North America General Medicines Market Size by Application
  6. 8.2.1 North America General Medicines Revenue by Application (2021-2032)
  7. 8.2.2 North America General Medicines Sales by Application (2021-2032)
  8. 8.2.3 North America General Medicines Price by Application (2021-2032)
  9. 8.3 North America General Medicines Market Size by Country
  10. 8.3.1 North America General Medicines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America General Medicines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America General Medicines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe General Medicines Market Size by Type
  2. 9.1.1 Europe General Medicines Revenue by Type (2021-2032)
  3. 9.1.2 Europe General Medicines Sales by Type (2021-2032)
  4. 9.1.3 Europe General Medicines Price by Type (2021-2032)
  5. 9.2 Europe General Medicines Market Size by Application
  6. 9.2.1 Europe General Medicines Revenue by Application (2021-2032)
  7. 9.2.2 Europe General Medicines Sales by Application (2021-2032)
  8. 9.2.3 Europe General Medicines Price by Application (2021-2032)
  9. 9.3 Europe General Medicines Market Size by Country
  10. 9.3.1 Europe General Medicines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe General Medicines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe General Medicines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China General Medicines Market Size by Type
  2. 10.1.1 China General Medicines Revenue by Type (2021-2032)
  3. 10.1.2 China General Medicines Sales by Type (2021-2032)
  4. 10.1.3 China General Medicines Price by Type (2021-2032)
  5. 10.2 China General Medicines Market Size by Application
  6. 10.2.1 China General Medicines Revenue by Application (2021-2032)
  7. 10.2.2 China General Medicines Sales by Application (2021-2032)
  8. 10.2.3 China General Medicines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia General Medicines Market Size by Type
  2. 11.1.1 Asia General Medicines Revenue by Type (2021-2032)
  3. 11.1.2 Asia General Medicines Sales by Type (2021-2032)
  4. 11.1.3 Asia General Medicines Price by Type (2021-2032)
  5. 11.2 Asia General Medicines Market Size by Application
  6. 11.2.1 Asia General Medicines Revenue by Application (2021-2032)
  7. 11.2.2 Asia General Medicines Sales by Application (2021-2032)
  8. 11.2.3 Asia General Medicines Price by Application (2021-2032)
  9. 11.3 Asia General Medicines Market Size by Country
  10. 11.3.1 Asia General Medicines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia General Medicines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia General Medicines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA General Medicines Market Size by Type
  2. 12.1.1 SAMEA General Medicines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA General Medicines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA General Medicines Price by Type (2021-2032)
  5. 12.2 SAMEA General Medicines Market Size by Application
  6. 12.2.1 SAMEA General Medicines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA General Medicines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA General Medicines Price by Application (2021-2032)
  9. 12.3 SAMEA General Medicines Market Size by Country
  10. 12.3.1 SAMEA General Medicines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA General Medicines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA General Medicines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 General Medicines Value Chain Analysis
  2. 13.1.1 General Medicines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 General Medicines Production Mode & Process
  6. 13.2 General Medicines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 General Medicines Distributors
  9. 13.2.3 General Medicines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst